The European Union has launched an investigation into French pharmaceutical giant Sanofi over its vaccine business practices, raising concerns about potential antitrust violations. The probe, announced this week, seeks to determine whether Sanofi engaged in unfair competitive behavior that may have affected vaccine supply and pricing across EU member states. This development comes amid heightened scrutiny of pharmaceutical companies as governments strive to secure adequate vaccine doses in the ongoing public health landscape.
EU Launches Investigation into Sanofi’s Vaccine Business Practices
The European Commission has formally opened a detailed investigation into the vaccine marketing and distribution strategies employed by the French pharmaceutical giant Sanofi. This move comes amid growing concerns about potential anti-competitive practices that may have impacted vaccine availability and pricing across EU member states during critical periods of public health emergencies….
—-
Author : Olivia Williams
Publish date : 2025-10-01 13:08:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
